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Abstract
Background: The aim of this study was to review a series of consecutive percutaneous cholecystosto-
mies (PC) to analyse the clinical outcomes.
Methods: All patients who underwent a PC between 2000 and 2010 were reviewed retrospectively for
indications, complications, and short- and long-term outcomes.
Results: Fifty-three patients underwent a PC with a median age was 74 years (range 14–93). 92.4%
(n = 49) of patients were American Society of Anesthesiologists (ASA) III and IV. 82% (43/53) had
ultrasound-guided drainage whereas 18% (10/53) had computed tomography (CT)-guided drainage.
71.6% (n = 38) of PC's employed a transhepatic route and 28.4% (n = 15) transabdominal route. 13%
(7/53) of patients developed complications including bile leaks (n = 5), haemorrhage (n = 1) and a
duodenal fistula (n = 1). All bile leaks were noted with transabdominal access (5 versus 0, P = 0.001). 18/53
of patients underwent a cholecystectomy of 4/18 was done on the index admission. 6/18 cholecystec-
tomies (33%) underwent a laparoscopic cholecystectomy and the remaining required conversion to an
open cholecystectomy (67%). 13/53 (22%) patients were readmitted with recurrent cholecystitis during
follow-up of which 7 (54%) had a repeated PC. 12/53 patients died on the index admission. The overall
1-year mortality was 37.7% (20/53).
Conclusions: Only a small fraction of patients undergoing a PC proceed to a cholecystectomy with a
high risk of conversion to an open procedure. A quarter of patients presented with recurrent cholecystitis
during follow-up. The mortality rate is high during the index admission from sepsis and within the 1 year
of follow-up from other causes.
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Introduction
Acute cholecystitis is a common cause of acute surgical admis-
sions and an early cholecystectomy at the index admission is a
widely accepted method of treatment.1 A laparoscopic cholecys-
tectomy for acute cholecystitis in selected patients is associated
with a good outcome with minimal morbidity.2 However, the
morbidity and mortality rates are significantly higher in high-risk
groups to as high a 14–46%.3 A percutaneous cholecystectomy
(PC) is a commonly used procedure to treat acute cholecystitis in
patients with significant co-morbid disease,4 either as a bridging
procedure in patients with severe sepsis5 followed by an interval
cholecystectomy or a definitive procedure in patients who are
unlikely to be fit for further surgery.6–8 This study aims to define
the indications, complications and clinical outcomes of a PC in
the treatment of acute cholecystitis at two university hospitals.
Methods
All consecutive patients who underwent a PC at two university
hospitals, Ninewells Hospital, Dundee, UK and Auckland City
Hospital (ACH), Auckland, New Zealand between January 2000
and October 2010 were reviewed from a prospectively maintained
patient database.
The data collected included demographics, indications,
American Society of Anesthesiologists (ASA) grading, duration of
symptoms, results of laboratory and radiological investigations
and the interval between admission and PC. The clinical outcomes
included the duration of hospital stay, duration of PC catheter
retention, presence of common bile duct stones, index cholecys-
tectomy, morbidity and mortality. In addition, data on readmis-
sions with recurrent cholecystitis requiring a repeat PC and 1-year
mortality were obtained.
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Definitions
Acute cholecystitis was defined as right upper quadrant pain asso-
ciated with pyrexia, leucocytosis>11 ¥ 109/ml, and ultrasound/
computed tomography (CT) evidence of acute inflammation. The
severity grading of acute cholecystitis was made according to the
Tokyo Guidelines.9
Technique of percutaneous cholecystostomy
The PC was performed by consultant interventional radiologists
under CT or ultrasound guidance. The later was used in conjunc-
tion with fluoroscopic screening to more accurately guide place-
ment. A similar technique was used in both centres. The choice of
modality varied according to the personal preference of the opera-
tor. A transhepatic approach was the preferred option as it reduces
the risk of bile leak. However, a transperitoneal approach was
employed when the gall bladder was grossly distended and adher-
ent to the abdominal wall, or when an unfavourable anatomy
renders transhepatic access very difficult.
Ultrasound or CT was used to guide the site of local anaesthetic
and the subsequent cholecystostomy. Access was achieved using
the Seldinger technique, in which a fine bore needle is initially
directed into the gallbladder. If using CT guidance, the position of
the needle, wires and catheter were identified on sequential
focused CT scans. Contrast was not usually required. However, for
fluoroscopic screening, contrast was instilled via the needle to
ensure accurate placement of the needle tip within the gallbladder
lumen. Using a series of dilators and wires, the tract was dilated to
site a pigtail catheter (Flexima; Boston Scientific, Natick, MA,
USA). The size of the catheter depended on the viscosity of the
gallbladder contents but an 8-F was typical. The gallbladder con-
tents were aspirated and sent for cultures, after which the catheter
was left on free drainage.
The PC catheters were left in situ for a minimum period of 6
weeks prior to removal. Prior to removal of the catheter, all
patients underwent a cholangiogram through the cholecysto-
stomy to ensure flow of contrast into the common bile duct
(CBD) and also to exclude CBD obstruction from stones. In the
presence of CBD stones, an endoscopic retrograde cholangiopan-
creatography (ERCP) was performed to clear the CBD prior to
removal of the catheter.
Statistical analysis
Statistical analysis was performed using SPSS software version 17
(SPSS, Chicago, IL, USA). Continuous data were described using
median and range. Fisher’s exact tests were used to analyse cat-
egorical data. A two-tailed P-value less than 0.05 was considered
statistically significant.
Results
A total of 53 patients were identified with a median age of 74
years (range, 14–93). The demographics, ASA grading, laboratory
parameters and radiological investigations are summarized in
Table 1. Thirty-three patients (63%) had calculus cholecystitis,
whereas 20 (37%) had acalculous cholecystitis. Seventy-seven per
cent (41/53) of the patients had pericholecystic fluid confirming
inflammation. Based on the Tokyo guidelines,9 40 patients were
graded as grade 2 (moderate cholecystitis) and 13 patients as
grade 3 (severe cholecystitis) with no patients with grade 1 chole-
cystitis (mild cholecystitis). The imaging modalities and the
technique of PC (transhepatic versus transabdominal) are sum-
marized in Table 1.
Table 1 Patient demographics and pre-operative investigations
Age – median (range): 74 years (14–93 years)
Gender (male/female): 1.5:1
ASA grade – number of patients (%):
Grade I 1 (1.9%))
Grade II 3 (5.7%)
Grade III 18 (33.9%)
Grade IV 31 (58.5%)
Median duration symptoms(range): 1 (1–35) day(s)
Median duration from admission to PC
(range): 3 (1–15) day(s)
Laboratory investigations – median
(range):
WCC 14.33 (3.3-27.2) ¥ 109/l
CRP 188.35 (5–489) mg/l
Bilirubin 20.35 (3–75 mg/dl
ALP 180.07 (53–1160) u/l
ALT 52.22 (7–402) u/l
Radiological investigations – number of
patients (%)
Ultrasonography (US) 18 (33.9%)
CT scan 15 (28.3%)
US+CT scan 20 (37.7%)
PC technique
Transhepatic: 38 (71.6%)
Transabdominal: 15 (28.4%)
Imaging modality for PC
Ultrasound guided PC 43 (82%)
CT guided PC 10 (18%)
Microbiology
Sterile 19 (35.8%)
Escherichia coli 18
Klebsiella pneumoniae 7
Mixed growth 5
Enterococcus 3
Streptococcus milleri 1
PC, percutaneous cholecystostomy ; ASA, American Society of Anesthe-
siologists; WCC, white cell count; CRP, C-reactive protein; ALP, alkaline
phosphatase ALT, alanine aminotransferase.
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Clinical outcomes
Twelve patients required intensive care unit (ICU) admission for
organ failure and sepsis for optimization after PC. The median
ICU stay was 6 days (range 4–11). The median hospital stay was
15.5 days (range 7–120). Seven patients (13%) developed
procedure-related complications including bile leaks (n = 5),
haemorrhage (n = 1) and a duodenal fistula (n = 1). All bile leaks
were noted with transabdominal access (5, transabdominal
versus 0, transhepatic, P = 0.001). Four bile leaks were managed
with percutaneous radiological drainage of the collection. One
patient underwent a laparotomy wash out and a cholecystectomy
to control the leak. One patient, who was ASA grade IV, devel-
oped a significant haemorrhage from the gallbladder bed after
the PC; however, declined any blood product transfusion and
died from hypotensive shock. One choledochoduodenal fistula
was noted on follow-up cholangiogram which was managed
conservatively.
Six patients with deranged liver function tests were found to
have CBD stones on magnetic resonance cholangiopancreatogra-
phy (MRCP) and underwent an ERCP and retrieval of the stones.
Amongst 13 patients who were admitted with grade 3 cholecysti-
tis, 12 died on the same admission.
The median time to removal of the PC catheter was 43 days
(range: 28–114). The patients who underwent an index cholecys-
tectomy had the drain removed at surgery. There was one
instance of catheter dislodgement resulting in bile leak requiring
an emergency laparotomy and a cholecystectomy and the patient
subsequently died from sepsis and multiorgan failure. One
patient had the catheter left for 114 days as he was lost to
follow-up until he represented to the hospital with an unrelated
medical problem at which point it was removed. There were no
instances of the need to leave the PC catheter in situ because of
obstruction at the cystic duct. The median overall follow-up was
910 days (range 53 days–9.3 years).
Surgical treatment
Thirty-four per cent (18/53) of patients eventually had a chole-
cystectomy. The surgical outcomes are summarized in Fig. 1.
Amongst the 18 patients who underwent surgery, 4 patients were
ASA I and II in whom a PC was planned as a bridging procedure.
In the remaining patients, a PC was used as a palliation for
control of sepsis; however, 14 patients became suitable for a
cholecystectomy after improvement in their overall condition.
The overall mortality during follow-up was 45% (n = 24/53).
Amongst these, 12/24 (50%) died on the index admission from
sepsis (n = 11) and haemorrhage (n = 1); and a further 8/24
(33.3%) died within the first year and the remaining > 1 year
(n = 4). The cause of death in the 12 patients during the follow-up
were pneumonia (n = 3), a myocardial infarction (n = 2), stroke
(n = 2), an intracranial bleed (n = 1), pancreatic cancer (n = 1), a
ruptured abdominal aortic aneurysm (n = 1), lung cancer (n = 1)
and recurrent sarcoma (n = 1).
Readmission
During follow-up, 13/53 (22%) of patients were readmitted with
recurrence of symptoms. The median time to representation was
151 days (63–510). Seven patients with readmission required a
repeat PC and the remaining patients were managed with antibi-
otic therapy with no further episodes during follow-up (Fig. 1).
All of these patients had the PC catheter removed at 6 weeks. 6/7
(92%) patients with readmission on PC catheter cholangiogram
at 6 weeks were noted to have a single large stone occluding the
cystic duct and 1/7 patient had multiple stones with an associated
CBD stone requiring ERCP and clearance of the duct. In all these
patients, the PC catheter was removed after the drain output was
minimal and non-bilious. No further readmissions were noted
during follow up. There were no procedure-related complications.
Calculus versus acalculous cholecystitis
A subgroup analysis was performed comparing calculus and acal-
culous cholecystitis regarding the need for high dependency care
and readmissions. 5/20 patients in the acalculous group required
HDU/ICU admission compared with 7/33 (P = 0.74). There were
4 (4/20, 20%) readmissions in the acalculous group compared
with 8 (8/33, 24%) in the calculus group (P = 1.00).
Discussion
The incidence of gallstone disease increases with the age.10 The
management of acute cholecystitis in the elderly and critically ill
patients can be challenging as a result of high mortality and mor-
bidity.11 PC can be an emergency lifesaving procedure in these
patients to resolve the acute phase with minimal intervention.
Once the patient recovers adequately, further management can be
either surgery or conservative management depending on the
patients’ co-morbid disease. In the present study, the indications
for PC were two-fold. First, as a bridging procedure in low-risk
patients (ASA grade I and II) who were severely septic, thus allow-
ing them to recover before a cholecystectomy could be per-
formed.12 Second, as a definitive procedure in high-risk patients
(ASA grade III and IV). In the present study, only a small fraction
of patients were suitable for definitive surgery either on the index
admission or at a later stage with a high conversion rate to an open
procedure. In the present series, PC was used as a bridging pro-
cedure in a 14-year-old patient with severe cholecystitis and sepsis
(ASA I) and three patients with ASA II who were considered high
risk for general anaesthesia owing to associated pneumonia.
The procedure-related morbidity for PC is between 8–44%
(Table 2). The majority of complications are related to failure to
place the catheter, catheter displacement, bile duct injury and
intracholecystic haemorrhage.13 In the literature, both the
transabdominal and transhepatic route have been described;
however, the transhepatic route appears to be the more favoured
route.12,14,15 In the present series, the most common procedural-
related morbidity was bile leak, requiring radiological interven-
tion and the placement of an abdominal drain to control the leak
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and this was more common with the transabdominal route. Based
on this, we currently reserve the transabdominal route when the
gall bladder is grossly distended and adherent to the abdominal
wall, or when unfavourable anatomy renders transhepatic access
very difficult.
The majority of the patients undergoing PC are generally unfit
for a cholecystectomy at initial presentation. Yun et al. reviewed a
series of 44 patients of which 34 patients underwent PC as a
bridging procedure and a subsequent cholecystectomy and the
rest as palliation for control of sepsis.12 On the contrary, other
studies have used PC as the definitive treatment for high-risk
patients unsuitable for surgery.7,29 In the present study, 18 patients
(33%) underwent a cholecystectomy. Four patients underwent PC
as a bridging procedure and underwent a cholecystectomy on the
index admission. Although in the remaining 14 patients the PC
was employed initially as a definitive treatment, during follow-up
they were deemed fit for a cholecystectomy and underwent
surgery albeit with a higher conversion rate.
The timing of removal of the PC catheter is a contentious issue.
The average time period reported in the literature is 4–6 weeks7,12
although some authors elected to remove the catheters on the
index admission after resolution of the sepsis.29 Our policy was to
leave the drain for 6 weeks to ensure resolution of inflammation
and to prevent bile leak after removal and a patent cystic and
bile duct after transcatheter cholangiography. The readmission
rate with recurrent cholecystitis in the present study was 22%.
Figure 1 Overall outcomes after a percutaneous cholecystostomy (PC)
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This is slightly higher than the readmission rates described in the
literature which range from 8% to 10%.14,29 More than half the
patients who were readmitted in the present series required a
repeat PC insertion. Single large stones occluding the drainage of
the cystic duct appeared to the most common cause. Although no
further interventions were needed apart from PC intervention,
several other interventional modalities were described in the lit-
erature such as percutaneous cystic duct stent insertion31 and
fluoroscopy guided gallstone removal30 to prevent recurrent
attacks.
A third of patients in the current series presented with acalculus
cholecystitis. Although acalculus cholecystitis is historically more
common in patients in severe comorbid disease,32 there was no
significant difference noted in the need for high-dependency care
and readmissions between calculus and acalculus cholecystitis in
the present series. In addition, although there is suggestion of
gallbladder wall ischaemia and necrosis in patients with acalculus
cholecystitis necessitating an open cholecystostomy,32 more recent
evidence and the data from the present series suggests a PC is
safe with good post procedure outcomes and with advancing
radiological techniques is increasingly becoming the technique of
choice over an open procedure (Table 2). This is further reflected
in the paucity of publications related to an open cholecystostomy
in the recent past.
In conclusion, the present series has shown that a PC is a viable
option for patients with acute cholecystitis when an immediate
cholecystectomy is found to be unsafe. The procedure-related
morbidity is acceptable and a third of patients subsequently
undergo a cholecystectomy albeit with a higher conversion rate. A
third of patients are readmitted with recurrent symptoms which
are manageable with a repeat PC. The in-hospital mortality and
the 1-year mortality were high reflecting the comorbid status of
the population.
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